UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 229

Sortiert nach

Dysregulation of estrogen receptor beta (ERβ), aromatase (CYP19A1), and ER co-activators in the middle frontal gyrus of autism spectrum disorder subjects

Molecular autism, 2014-09, Vol.5 (1), p.46-46, Article 46

2014

Link zum Volltext

Verfügbarkeit prüfen

Do cognitive deficits predict negative emotionality and aggression in schizophrenia?

Psychiatry research, 2018-01, Vol.259, p.350-357

2018

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Have We Got Better in Making Our Schizophrenia Patients Better?

Frontiers in psychiatry, 2020-11, Vol.11, p.618417-618417

2020

Link zum Volltext

Verfügbarkeit prüfen

Altered mRNA Levels of Glucocorticoid Receptor, Mineralocorticoid Receptor, and Co-Chaperones (FKBP5 and PTGES3) in the Middle Frontal Gyrus of Autism Spectrum Disorder Subjects

Molecular neurobiology, 2016-05, Vol.53 (4), p.2090-2099

2016

Link zum Volltext

Verfügbarkeit prüfen

Exploring current smartphone-based cognitive assessments in schizophrenia and bipolar disorder

Schizophrenia research. Cognition, 2024-09, Vol.37, p.100309-100309, Article 100309

2024

Link zum Volltext

Verfügbarkeit prüfen

An examination of neurocognition and symptoms as predictors of post-hospital community tenure in treatment resistant schizophrenia

Psychiatry research, 2016-02, Vol.236, p.47-52

2016

Link zum Volltext

Verfügbarkeit prüfen

Transglutaminase 2 Induces Deficits in Social Behavior in Mice

Neural plasticity, 2018-01, Vol.2018, p.2019091-9

2018

Link zum Volltext

Verfügbarkeit prüfen

Reconsidering the Latent Structure of Negative Symptoms in Schizophrenia: A Review of Evidence Supporting the 5 Consensus Domains

Schizophrenia bulletin, 2019-06, Vol.45 (4), p.725-729

2019

Link zum Volltext

Verfügbarkeit prüfen

What Do These Findings Tell Us? Comment on Tinella et al. Cognitive Efficiency and Fitness-to-Drive along the Lifespan: The Mediation Effect of Visuospatial Transformations. Brain Sci. 2021, 11 , 1028

Brain sciences, 2022-01, Vol.12 (2), p.165

2022

Link zum Volltext

Verfügbarkeit prüfen

The Latent Structure of Negative Symptoms in Schizophrenia

JAMA psychiatry (Chicago, Ill.), 2018-12, Vol.75 (12), p.1271

2018

Link zum Volltext

Verfügbarkeit prüfen

The Quest for Psychiatric Advancement through Theory, beyond Serendipity

Brain sciences, 2021-12, Vol.12 (1), p.72

2021

Link zum Volltext

Verfügbarkeit prüfen

Complement component 3a receptor deficiency attenuates chronic stress-induced monocyte infiltration and depressive-like behavior

Brain, behavior, and immunity, 2018-05, Vol.70, p.246-256

2018

Link zum Volltext

Verfügbarkeit prüfen

Schizophrenia heterogeneity revisited: Clinical, cognitive, and psychosocial correlates of statistically-derived negative symptoms subgroups

Journal of psychiatric research, 2018-02, Vol.97, p.8-15

2018

Link zum Volltext

Verfügbarkeit prüfen

Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in Schizophrenia

Schizophrenia bulletin, 2019-03, Vol.45 (2), p.305-314

2019

Link zum Volltext

Verfügbarkeit prüfen

Peers and Peer-Led Interventions for People with Schizophrenia

The Psychiatric clinics of North America, 2012-09, Vol.35 (3), p.699-715

2012

Link zum Volltext

Verfügbarkeit prüfen

Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: A meta-analysis

Psychiatry research, 2015-03, Vol.226 (1), p.1-13

2015

Link zum Volltext

Verfügbarkeit prüfen

Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia With Taxometric and Latent Variable Mixture Models

Schizophrenia bulletin, 2015-07, Vol.41 (4), p.879-891

2015

Link zum Volltext

Verfügbarkeit prüfen

Association between adverse childhood experiences and suicidal behavior in schizophrenia spectrum disorders: A systematic review and meta-analysis

Psychiatry research, 2023-11, Vol.329, p.115488-115488, Article 115488

2023

Link zum Volltext

Verfügbarkeit prüfen

Performance on a contour integration task as a function of contour shape in schizophrenia and controls

Vision research (Oxford), 2024-06, Vol.219, p.108394-108394, Article 108394

2024

Link zum Volltext

Verfügbarkeit prüfen

Computerized cognitive and social cognition training in schizophrenia for impulsive aggression

Schizophrenia research, 2023-06, Vol.256, p.117-125

2023

Link zum Volltext

Verfügbarkeit prüfen

Cognitive Remediation for Schizophrenia

Focus (American Psychiatric Publishing), 2020-10, Vol.18 (4), p.436-439

Ahmed, Anthony O

2020

Link zum Volltext

Verfügbarkeit prüfen

Two Factors, Five Factors, or Both? External Validation Studies of Negative Symptom Dimensions in Schizophrenia

Schizophrenia bulletin, 2022-05, Vol.48 (3), p.620-630

2022

Link zum Volltext

Verfügbarkeit prüfen

A Meta-Analysis of Brain-Derived Neurotrophic Factor Effects on Brain Volume in Schizophrenia: Genotype and Serum Levels

Neuropsychobiology, 2021-10, Vol.80 (5), p.411-424

2021

Link zum Volltext

Verfügbarkeit prüfen

Type 1 interferon mediates chronic stress-induced neuroinflammation and behavioral deficits via complement component 3-dependent pathway

Molecular psychiatry, 2021-07, Vol.26 (7), p.3043-3059

2021

Link zum Volltext

Verfügbarkeit prüfen

The brief negative symptom scale (BNSS): Sensitivity to treatment effects

Schizophrenia research, 2018-07, Vol.197, p.269-273

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 229

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(211)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Dysregulation of estrogen receptor beta (ERβ), aromatase (CYP19A1), and ER co-activators in the middle frontal gyrus of autism spectrum disorder subjects

Do cognitive deficits predict negative emotionality and aggression in schizophrenia?

Editorial: Have We Got Better in Making Our Schizophrenia Patients Better?

Altered mRNA Levels of Glucocorticoid Receptor, Mineralocorticoid Receptor, and Co-Chaperones (FKBP5 and PTGES3) in the Middle Frontal Gyrus of Autism Spectrum Disorder Subjects

Exploring current smartphone-based cognitive assessments in schizophrenia and bipolar disorder

An examination of neurocognition and symptoms as predictors of post-hospital community tenure in treatment resistant schizophrenia

Transglutaminase 2 Induces Deficits in Social Behavior in Mice

Reconsidering the Latent Structure of Negative Symptoms in Schizophrenia: A Review of Evidence Supporting the 5 Consensus Domains

What Do These Findings Tell Us? Comment on Tinella et al. Cognitive Efficiency and Fitness-to-Drive along the Lifespan: The Mediation Effect of Visuospatial Transformations. Brain Sci. 2021, 11 , 1028

The Latent Structure of Negative Symptoms in Schizophrenia

The Quest for Psychiatric Advancement through Theory, beyond Serendipity

Complement component 3a receptor deficiency attenuates chronic stress-induced monocyte infiltration and depressive-like behavior

Schizophrenia heterogeneity revisited: Clinical, cognitive, and psychosocial correlates of statistically-derived negative symptoms subgroups

Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in Schizophrenia

Peers and Peer-Led Interventions for People with Schizophrenia

Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: A meta-analysis

Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia With Taxometric and Latent Variable Mixture Models

Association between adverse childhood experiences and suicidal behavior in schizophrenia spectrum disorders: A systematic review and meta-analysis

Performance on a contour integration task as a function of contour shape in schizophrenia and controls

Computerized cognitive and social cognition training in schizophrenia for impulsive aggression

Cognitive Remediation for Schizophrenia

Two Factors, Five Factors, or Both? External Validation Studies of Negative Symptom Dimensions in Schizophrenia

A Meta-Analysis of Brain-Derived Neurotrophic Factor Effects on Brain Volume in Schizophrenia: Genotype and Serum Levels

Type 1 interferon mediates chronic stress-induced neuroinflammation and behavioral deficits via complement component 3-dependent pathway

The brief negative symptom scale (BNSS): Sensitivity to treatment effects

Suchergebnisse filtern